Biogen Inc. (BIIB) Q4 2025 (USD): adj. EPS 1.99 (exp. 1.62), Revenue 2.3bln (exp. 2.20bln)
Importance
Level 1
GUIDANCE:
- FY EPS view 15.25-16.25 (exp. 15.01)
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#BIOGEN IDEC INC#BIIB.US#FOREX#EQUITIES#METALS#EU SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#BIOGEN INC#BIIB#DXY#US EQUITIES